Ruimin Hao

发表论文 2 篇 · 总被引 4 次 · h-index 1

代表论文

• Anti‐tumor drug supervision in China from 2010 to 2024: the evolution and prospect of drug review standards (2024 · Cancer Communications · 被引 4)
• 境外授权许可引进抗肿瘤新药临床研发策略的审评考虑 (2022 · Zhongguo fei ai za zhi = Chinese journal of lung cancer)